BR9909981A - Soluções de mitoxantrona estáveis - Google Patents
Soluções de mitoxantrona estáveisInfo
- Publication number
- BR9909981A BR9909981A BR9909981-0A BR9909981A BR9909981A BR 9909981 A BR9909981 A BR 9909981A BR 9909981 A BR9909981 A BR 9909981A BR 9909981 A BR9909981 A BR 9909981A
- Authority
- BR
- Brazil
- Prior art keywords
- stable
- solutions
- stable mitoxantrone
- solution
- mitoxantrone solutions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Patente de Invenção: <B>"SOLUçõES DE MITOXANTRONA ESTáVEIS"<D>. é descrita uma solução de mitoxantrona estável, que para a estabilização contém 0,001 até 0,15% de edetato de sódio. A solução injetável é isenta de compostos sulfeto e evita seus efeitos colaterais na aplicação parenteral.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19818802A DE19818802A1 (de) | 1998-04-27 | 1998-04-27 | Stabile Mitoxantron-Lösungen |
PCT/EP1999/002290 WO1999055375A1 (de) | 1998-04-27 | 1999-04-01 | Stabile mitoxantron-lösungen |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9909981A true BR9909981A (pt) | 2000-12-26 |
Family
ID=7865948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9909981-0A BR9909981A (pt) | 1998-04-27 | 1999-04-01 | Soluções de mitoxantrona estáveis |
Country Status (18)
Country | Link |
---|---|
US (1) | US6143795A (pt) |
EP (1) | EP1073469B1 (pt) |
JP (1) | JP2002512981A (pt) |
CN (1) | CN1195548C (pt) |
AR (1) | AR018198A1 (pt) |
AT (1) | ATE282431T1 (pt) |
AU (1) | AU744502B2 (pt) |
BG (1) | BG64767B1 (pt) |
BR (1) | BR9909981A (pt) |
CA (1) | CA2270004C (pt) |
CO (1) | CO5021217A1 (pt) |
DE (2) | DE19818802A1 (pt) |
HK (1) | HK1036012A1 (pt) |
HU (1) | HUP0102075A3 (pt) |
NZ (1) | NZ507407A (pt) |
RU (1) | RU2219917C2 (pt) |
TW (1) | TWI224003B (pt) |
WO (1) | WO1999055375A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0005703D0 (en) * | 2000-03-09 | 2000-05-03 | Alpharma As | Compounds |
SI1615646T2 (sl) | 2003-04-08 | 2022-11-30 | Progenics Pharmaceuticals, Inc. | Farmacevtske formulacije vsebujoče metilnatrekson |
CN102397561B (zh) * | 2011-09-26 | 2013-03-06 | 沈阳药科大学 | 米托蒽醌作为淋巴示踪剂的应用 |
JP5589110B1 (ja) * | 2013-03-08 | 2014-09-10 | 株式会社ポーラファルマ | 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物 |
CN107149592B (zh) * | 2017-06-23 | 2019-10-08 | 沈阳天邦药业有限公司 | 具有淋巴靶向功能的生物自组装纳米晶注射剂及制备方法 |
CN113730603B (zh) * | 2020-05-27 | 2023-01-24 | 深圳华润九创医药有限公司 | 米托蒽醌制剂在制备诊治与甲状腺切除相关的疾病的药物中的应用 |
CN114601791B (zh) * | 2020-12-08 | 2023-09-19 | 成都倍特药业股份有限公司 | 一种盐酸米托蒽醌液体制剂及其制备方法 |
CN114732807A (zh) * | 2022-03-27 | 2022-07-12 | 苏州大学 | 米托蒽醌在制备预防或治疗急性移植物抗宿主病药物中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3248291A (en) * | 1963-08-19 | 1966-04-26 | Hoffmann La Roche | Stabilized thioxanthene derivatives and method of using the same |
ES2033247T3 (es) * | 1986-03-07 | 1993-03-16 | American Cyanamid Company | Metodo para preparar una composicion farmaceutica a base de un compuesto antraquinonico. |
IL83086A (en) * | 1987-07-06 | 1991-03-10 | Teva Pharma | Stable,injectable solutions of vincristine salts |
DE3825374A1 (de) * | 1988-07-26 | 1990-02-01 | Schwendener Reto Dipl Apotheke | Komplex aus mindestens einer lipophilen saeure und mitoxantron und/oder bisantren |
AU5680994A (en) * | 1992-12-10 | 1994-07-04 | Abbott Laboratories | Stabilized catecholamine solutions |
FR2758264B1 (fr) * | 1997-01-16 | 1999-03-26 | Charles Dumontet | Compositions medicamenteuses contenant de l'edta ou un de ses derives pour la prevention de la toxicite cutanee et sous-cutanee des anthracyclines et de leurs derives |
-
1998
- 1998-04-27 DE DE19818802A patent/DE19818802A1/de not_active Ceased
-
1999
- 1999-04-01 RU RU2000129666/14A patent/RU2219917C2/ru active
- 1999-04-01 CN CNB998055794A patent/CN1195548C/zh not_active Expired - Fee Related
- 1999-04-01 AT AT99916906T patent/ATE282431T1/de not_active IP Right Cessation
- 1999-04-01 HU HU0102075A patent/HUP0102075A3/hu unknown
- 1999-04-01 EP EP99916906A patent/EP1073469B1/de not_active Expired - Lifetime
- 1999-04-01 NZ NZ507407A patent/NZ507407A/xx unknown
- 1999-04-01 JP JP2000545572A patent/JP2002512981A/ja active Pending
- 1999-04-01 AU AU35225/99A patent/AU744502B2/en not_active Ceased
- 1999-04-01 WO PCT/EP1999/002290 patent/WO1999055375A1/de active IP Right Grant
- 1999-04-01 DE DE59911099T patent/DE59911099D1/de not_active Expired - Fee Related
- 1999-04-01 BR BR9909981-0A patent/BR9909981A/pt not_active Application Discontinuation
- 1999-04-07 CO CO99020294A patent/CO5021217A1/es unknown
- 1999-04-23 TW TW088106569A patent/TWI224003B/zh not_active IP Right Cessation
- 1999-04-26 US US09/299,131 patent/US6143795A/en not_active Expired - Fee Related
- 1999-04-26 CA CA002270004A patent/CA2270004C/en not_active Expired - Fee Related
- 1999-04-27 AR ARP990101932A patent/AR018198A1/es unknown
-
2000
- 2000-10-12 BG BG104850A patent/BG64767B1/bg unknown
-
2001
- 2001-09-24 HK HK01106731A patent/HK1036012A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1073469B1 (de) | 2004-11-17 |
AR018198A1 (es) | 2001-10-31 |
CN1195548C (zh) | 2005-04-06 |
ATE282431T1 (de) | 2004-12-15 |
HUP0102075A2 (hu) | 2002-05-29 |
BG104850A (en) | 2001-05-31 |
BG64767B1 (bg) | 2006-03-31 |
WO1999055375A1 (de) | 1999-11-04 |
US6143795A (en) | 2000-11-07 |
AU744502B2 (en) | 2002-02-28 |
EP1073469A1 (de) | 2001-02-07 |
HK1036012A1 (en) | 2001-12-21 |
CO5021217A1 (es) | 2001-03-27 |
AU3522599A (en) | 1999-11-16 |
CA2270004C (en) | 2004-06-01 |
CA2270004A1 (en) | 1999-10-27 |
DE19818802A1 (de) | 1999-10-28 |
CN1298310A (zh) | 2001-06-06 |
HUP0102075A3 (en) | 2002-10-28 |
DE59911099D1 (de) | 2004-12-23 |
RU2219917C2 (ru) | 2003-12-27 |
NZ507407A (en) | 2002-08-28 |
TWI224003B (en) | 2004-11-21 |
JP2002512981A (ja) | 2002-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9911579A (pt) | Uso de um composto antimicrobiano para desinfecção | |
BR0014869A (pt) | Composição e método para estabilização da mesma | |
BR0016555A (pt) | Composições farmacêuticas que proporcionam concentrações acrescidas de droga | |
BR9916211A (pt) | Derivados de 3,4-diamino-3-ciclobuteno-1,2-diona que inibem adesão de leucócito mediada por vla-4 | |
BR0007472A (pt) | Agente contendo paramilonas, seco por congelação, sua produção e utilização | |
AR002718A1 (es) | Acidos hidroxamicos que contienen lactamas y composicion farmaceutica con los mismos. | |
BR9900320A (pt) | Composição antimicrobiana | |
BR9908020A (pt) | Fórmula para polimento ótico | |
BR9915755A (pt) | Anti-inflamátorio não-esteroidal | |
BR0107027A (pt) | Composição cosmética ou farmacêutica que se apresenta em forma sólida compreendendo bis-acilamidas | |
ATE293967T1 (de) | Zusammensetzungen enthaltend stilbenoide mit einer hypoglykämischen wirkung | |
BR9915986A (pt) | Estabilização de macrolìdios | |
BR0010562A (pt) | Inibidor de metaloprotease do ácido hidrox mico de sulfona aromática | |
BR9810435A (pt) | Composição cosmética, uso da mesma, e uso de um sal de ácido orgânico de uma biguanida polimérica. | |
DK0750631T3 (da) | Mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[c]azepin-3-ondisulfidderivater som enkephalinase- og ACE-inhibitorer | |
SE9802974D0 (sv) | New crystalline forms | |
ATE252572T1 (de) | 5-ht1f agonisten | |
AU6593301A (en) | Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds | |
KR870003974A (ko) | 비시클로 치환된 페닐아세토니트릴 유도체 | |
BR9909981A (pt) | Soluções de mitoxantrona estáveis | |
BR9916504A (pt) | Hidroxamatos de sulfonamida | |
BR9915692A (pt) | Monohidrato de bromidrato de eletriptano | |
BR0113650A (pt) | N-(3,5-dicloro-2-metoxifenil)-4-metóxi-3-piperazina-1-il a-benzenossulfonamida | |
BR9911464A (pt) | Métodos de inibição de corrosão usando isÈmeros de cloro-metilbenzotriazol | |
BR9903981A (pt) | Metilciclotetradec-5-en-1-onas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, COM BASE NOS ARTIGOS 8O E 13 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |